Literature DB >> 14582754

Pedicled myocutaneous and muscle flaps in the management of complicated cardiothoracic problems.

Theodosios Dosios1, Othon Papadopoulos, Dimitrios Mantas, Panagis Georgiou, Panayotis Asimacopoulos.   

Abstract

The purpose of this study was to review our experience with the management of patients with complicated cardiothoracic problems by the use of pedicled myocutaneous or muscle flaps, and discuss the various methods of reconstruction. Over the last 11 years, we have treated 54 patients with complicated cardiothoracic problems by reconstruction with pedicled myocutaneous or muscle flaps. The underlying causes were chest wall tumours (n = 13), radionecrosis of the chest wall (n = 12), deep or chronic sternal infections (n = 25), and bronchopleural fistulas (n = 4). The most commonly used muscles for reconstruction were pectoralis major and the rectus abdominis. Our results compare favourably with those reported elsewhere. We conclude that although the use of pedicled myocutaneous or muscle flaps is not free of complications, it is an effective and reliable method for the management of patients with complicated cardiothoracic problems.

Entities:  

Mesh:

Year:  2003        PMID: 14582754     DOI: 10.1080/02844310310000671

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg Hand Surg        ISSN: 0284-4311


  3 in total

1.  Pedicled latissimus dorsi muscle flap: routine use in high-risk thoracic surgery.

Authors:  Amir Abolhoda; Trung D Bui; Jeffrey C Milliken; Garrett A Wirth
Journal:  Tex Heart Inst J       Date:  2009

Review 2.  Sternal reconstruction after post-sternotomy mediastinitis.

Authors:  Pankaj Kaul
Journal:  J Cardiothorac Surg       Date:  2017-11-02       Impact factor: 1.637

3.  Cryopreserved aortic homograft, lifeline treatment for infected vascular prosthesis with mediastinal abscess in a re-redo case.

Authors:  Magdalena Rufa; Adrian Ursulescu; Alina Stan; Nora Göbel; Marc Albert; Ulrich F W Franke
Journal:  J Surg Case Rep       Date:  2022-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.